©The Author(s) 2025.
World J Gastrointest Endosc. Dec 16, 2025; 17(12): 111782
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111782
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111782
Table 3 Outcomes of through the scope clips and over the scope clips in the management of gastrointestinal tract defects
| Ref. | Study design | Population characteristics | Outcomes in the clip cohort | Outcomes in control cohort | Additional information |
| Kirschniak et al[29], 2011 | Retrospective | n = 50, GI Bleed: n = 27. Perforation: n = 11. Fistulae: n = 8. Pre-op marking: n = 4 | Primary success: 100%. Recurrence of GI bleed: 2 (7.4%). Recurrence of fistulae: 5 (62.5%). No recurrence of perforation | NA | High recurrence of fistulae despite initial success |
| Hagel et al[34], 2012 | Prospective | n = 17 (Iatrogenic perforations: n = 6. AL: n = 3. Complication of PEG: n = 5. Duodenal ulcer perforation: n = 3). Median age: 71 ± 7 years | Successful closure: 11 (64.7%) | NA | Six unsuccessful cases had larger perforation defects and had necrotic or soft inflammatory margins |
| Voermans et al[33], 2012 | Prospective, multicenter | n = 36. Acute iatrogenic perforations. Location: Esophageal: n = 5. Gastric: n = 6. Duodenal: n = 12. Colonic: n = 13. M: 15; F: 21 | Successful closure: 33 (92%). Clinical success: 32 (89%). Surgery: n = 4. Death: n = 1 | NA | Death occurred in one patient with colonic perforation (even after surgery) |
| Lee et al[13], 2013 | Retrospective | 35 patients with AL after surgery for gastric cancer. M: n = 27, F: n = 8. Median age: 64 Y | n = 20. Technical clinical success: 19 (95%). Surgery due to failed endoscopic t/t: n = 1. Death: n = 0 | n = 15. Death: n = 5. Cause of death: Sepsis, bleeding, HAP | Endoscopic modality: Hemoclips: n = 17. Detachable snare: n = 2. Additional fibrin glue: n = 14 |
| Haito-Chavez et al[35], 2014 | Multicenter, retrospective | n = 188. Fistulae: n = 108. Perforations: n = 48. AL: n = 32 | Overall success: 60.2%. Success rate for perforations: 90%. Success rate for AL: 73.3%. Success rate for fistulae: 42.9% | NA | Success rate is significantly higher for acute defects (like perforations/AL) than for chronic defects (fistulae). Success rate is significantly higher if OTSC is applied for primary therapy (69.1%) than for rescue therapy (46.9%; P = 0.004) |
| Law et al[37], 2015 | Retrospective | n = 47. Mean age: 57 ± 14. M: 24; F: 23. Fistula location: Esophagus: n = 3. Stomach: n = 16. Small bowel: n = 18. Colo-rectum: n = 10 | Initial technical success: 42 (89%). Fistula recurrence: 25 (53%) at median f/u of 178 days | NA | Poor long-term outcomes of OTSC: Fistula recurrence around 50% despite OTSC retention |
| Verlaan et al[14], 2015 | SRMA | 24 studies; 21 retrospective, 3 prospective, no RCT. n = 466 Hemoclips: n = 398. OTSC: n = 66. Stents: n = 2 | Successful outcome: 419 (89.9%). Success rate of hemoclips: 359 (90.2%). Success rate of OTSC: 58 (87.8%). Success rate of stents: 2 (100%) | NA | Limited by the low methodological quality of included studies |
| Kobara et al[39], 2019 | SRMA | 30 studies. n = 1517 | Clinical success rate: For perforation: 85% (n = 351). For AL: 66% (n = 97). For fistulae: 52% (n = 388) | NA | Overall complications: 1.7% (n = 23). Severe complications: 0.59% (n = 9) |
- Citation: Birda CL, Dhar J, Kumar N, Mishra S, Dell'Anna G, Tandup C, Nagaraj SS, Crinò SF, Mitra V, Nabi Z, Samanta J. Endoscopic management for gastrointestinal leaks, perforations, and fistulae: Technical tips and outcomes. World J Gastrointest Endosc 2025; 17(12): 111782
- URL: https://www.wjgnet.com/1948-5190/full/v17/i12/111782.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i12.111782